Commentary: Are we at a CROSSroads in neoadjuvant therapy for esophageal cancer?

被引：0
|
作者：
Broderick, Stephen R. [1 ]
机构：
[1] Johns Hopkins Med Inst, Dept Surg, Div Thorac Surg, 600 N Wolfe St,Blalock 240, Baltimore, MD 21287 USA
来源：
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2023年 / 165卷 / 03期
关键词：
CHEMORADIOTHERAPY;
D O I：
10.1016/j.jtcvs.2020.12.107
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e88 / e89
页数：2
相关论文
共 50 条
  • [21] Neoadjuvant therapy for esophageal cancer: Who, when, and what?
    Greally, Megan
    Ilson, David H.
    CANCER, 2018, 124 (22) : 4276 - 4278
  • [22] Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal
    Visser, BC
    Venook, AP
    Patti, MG
    SURGICAL ONCOLOGY-OXFORD, 2003, 12 (01): : 1 - 7
  • [23] Reassessment of patients with esophageal cancer after neoadjuvant therapy
    Das, A.
    Chak, A.
    ENDOSCOPY, 2006, 38 : S13 - S17
  • [24] Commentary: Octogenarians and Esophageal Cancer, Are We Afraid to Treat, or Are We Missing Information?
    Fetten, Katharina
    Onaitis, Mark
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2021, 33 (03) : 893 - 894
  • [25] Multimodal Therapy of Esophageal Cancer Neoadjuvant Chemotherapy vs. neoadjuvant Chemoradiotherapy
    Hoeppner, Jens
    ONKOLOGE, 2016, 22 (07): : 509 - 510
  • [26] Adjuvant Therapy After Neoadjuvant Therapy for Esophageal Cancer Who Needs It?
    Raja, Siva W.
    Rice, Thomas
    Lu, Min E.
    Semple, Marie H.
    Blackstone, Eugene C.
    Murthy, Sudish
    Ahmad, Usman
    McNamara, Michael J.
    Toth, Andrew
    Ishwaran, Hemant
    ANNALS OF SURGERY, 2023, 278 (02) : E240 - E249
  • [27] Utility of esophageal stenting for esophageal cancer patients with dysphagia undergoing neoadjuvant therapy
    Brown, R. E.
    St Hill, C. R.
    Harkenrider, M. M.
    Ellis, S.
    Sharma, V. R.
    El-Ghamry, M. N.
    Scoggins, C. R.
    McMasters, K. M.
    Abbas, A. E.
    Martin, R. C., II
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [28] Neoadjuvant therapy in rectal cancer: how are we choosing?
    Tinawi, Georges
    Gunawardene, Ashok
    Shekouh, Ali
    Larsen, Peter D.
    Dennett, Elizabeth R.
    ANZ JOURNAL OF SURGERY, 2019, 89 (1-2) : 68 - 73
  • [29] Defining Pathologic Upstaging in cT1b Esophageal Cancer: Should We Consider Neoadjuvant Therapy?
    Mann, David R.
    Engelhardt, Kathryn E.
    Gibney, Barry C.
    Batten, Macelyn E.
    Klipsch, Eric C.
    Mukherjee, Rupak
    Bostock, Ian C.
    JOURNAL OF SURGICAL RESEARCH, 2024, 295 : 61 - 69
  • [30] Accuracy of Clinical Staging with EUS for Early Stage Esophageal Cancer: Are We Denying Patients Beneficial Neoadjuvant Therapy?
    Luu, C.
    Garcia-Henriquez, N.
    Klapman, J. B.
    Harris, C. L.
    Almhanna, K.
    Hoffe, S.
    Pimiento, J. M.
    Fontaine, J.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S152 - S152
12345